Global Wealth Management Investment Advisory’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-45
Closed -$3K 621
2020
Q1
$3K Buy
+45
New +$3.25K ﹤0.01% 465
2019
Q4
Sell
-27
Closed -$2K 651
2019
Q3
$2K Hold
27
﹤0.01% 508
2019
Q2
$2K Hold
27
﹤0.01% 556
2019
Q1
$2K Hold
27
﹤0.01% 542
2018
Q4
$1K Buy
+27
New +$1.37K ﹤0.01% 638

Other funds holding EW

Global Wealth Management Investment Advisory's EW Position: Q2 2020 in Review

Global Wealth Management Investment Advisory sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 45 shares — an estimated $3K sold.

Global Wealth Management Investment Advisory first reported a position in EW in Q4 2018 and held it in 5 quarters. The position peaked at $3K in Q1 2020. 1,047 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • Global Wealth Management Investment Advisory reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 45 Edwards Lifesciences shares in Q2 2020, an estimated $3K.
  • Global Wealth Management Investment Advisory first reported a position in Edwards Lifesciences in Q4 2018 and held it in 5 quarters.
  • Global Wealth Management Investment Advisory's Edwards Lifesciences position peaked at $3K in Q1 2020.
  • 1,047 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Global Wealth Management Investment Advisory's 13F filing for Q2 2020, filed 12 Aug 2020.